or Try an Advanced Search...

    Technical Analysis for MOLN - Molecular Partners AG

    Grade Last Price % Change Price Change
    F 3.80 -0.26% -0.01
    MOLN closed down 0.26 percent on Friday, May 24, 2024, on 9 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical MOLN trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    50 DMA Resistance Bearish -0.26%
    20 DMA Support Bullish -0.26%
    Pocket Pivot Bullish Swing Setup -0.26%
    Volume Surge Other -0.26%
    Upper Bollinger Band Touch Strength -0.26%
    Oversold Stochastic Weakness -0.26%
    Crossed Above 20 DMA Bullish 0.00%
    Older End-of-Day Signals for MOLN ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % 4 days ago
    Down 1% 4 days ago
    Fell Below 20 DMA 4 days ago
    Fell Below 10 DMA 4 days ago
    Rose Above Previous Day's High 5 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MOLN Chart by TradingView
    Basic chart:

    Profile

    Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Pharmaceutical Drugs Infectious Diseases Molecular Partners

    Is MOLN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 29 Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action
    Apr 19 Life Science Cares Launches in Switzerland
    Apr 17 Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
    Mar 14 Earnings Scheduled For March 14, 2024
    Mar 1 Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
    Jan 8 Molecular Partners says data from projected therapeutically active doses of MP0533 from Phase 1/2a trial to be presented in H1
    Jan 7 Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
    Jan 5 Molecular Partners, Orano to collaborate on RDT therapies for cancer
    Jan 5 Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
    Dec 14 Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences
    See more MOLN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.32
    52 Week Low 3.32
    Average Volume 3,958
    200-Day Moving Average 4.50
    50-Day Moving Average 3.87
    20-Day Moving Average 3.75
    10-Day Moving Average 3.74
    Average True Range 0.24
    RSI (14) 50.25
    ADX 15.34
    +DI 35.36
    -DI 22.72
    Chandelier Exit (Long, 3 ATRs) 3.78
    Chandelier Exit (Short, 3 ATRs) 4.24
    Upper Bollinger Bands 3.95
    Lower Bollinger Band 3.55
    Percent B (%b) 0.62
    BandWidth 10.76
    MACD Line -0.03
    MACD Signal Line -0.05
    MACD Histogram 0.018
    Fundamentals Value
    Market Cap 124.85 Million
    Num Shares 32.9 Million
    EPS -2.09
    Price-to-Earnings (P/E) Ratio -1.82
    Price-to-Sales 17.37
    Price-to-Book 0.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.80
    Resistance 3 (R3) 3.80 3.80 3.80
    Resistance 2 (R2) 3.80 3.80 3.80 3.80
    Resistance 1 (R1) 3.80 3.80 3.80 3.80 3.80
    Pivot Point 3.80 3.80 3.80 3.80 3.80
    Support 1 (S1) 3.80 3.80 3.80 3.80 3.80
    Support 2 (S2) 3.80 3.80 3.80 3.80
    Support 3 (S3) 3.80 3.80 3.80
    Support 4 (S4) 3.80